Alexion Pharma (ALXN) Beats Q1 EPS Views by 8c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
FRMM, PETS, DARE, More
Financial Fact:
Income before income taxes: 169.97M
Today's EPS Names:
FRMM, PETS, DARE, More
Join SI Premium – FREE
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) reported Q1 EPS of $0.59, $0.08 better than the analyst estimate of $0.51. Revenue for the quarter came in at $166.1 million versus the consensus estimate of $165.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
